🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a dose finding study using a 3 + 3 dose escalation and expansion de...
Status
Completed
Location
Clearview Cancer Institute Oncology Specialties, P.C
Start Date
2012-12-28
Trial ID
NCT01732861
Treatments Being Tested
This is an open label, 3 + 3 dose escalation study, to determine the MTD, s...
Status
Completed
Location
Hopital henri mondor
Start Date
2013-02
Trial ID
NCT01766583
Treatments Being Tested
This is a dose finding study using a 3 + 3 dose escalation and expansion de...
Status
Completed
Location
Clearview Cancer Institute
Start Date
2012-12
Trial ID
NCT01744626
First study, at multiple clinical centers, exploring the effects of differe...
Status
Terminated
Location
Stanford Cancer Center
Start Date
2013-12-18
Trial ID
NCT02031419
CC-292 is an oral agent that is under clinical development for the treatmen...
Status
Completed
Location
Achieve Clinical Research LLC
Start Date
2013-10
Trial ID
NCT01975610
To evaluate the PK profile of the newly developed CC-292 SDD formulation co...
Status
Completed
Location
Covance Clinical Research unit
Start Date
2014-05-26
Trial ID
NCT02433457
Treatments Being Tested